Your Cart

Biotech Daily — Dr Boreham’s Crucible: Imagion Biosystems

Biotech Daily — Dr Boreham’s Crucible: Imagion Biosystems

Tim Boreham revisits Imagion Biosystems’ potential in this 5-1/2 page article profiling the company and discussing its recent milestones.

Read the article here.

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.